4.7 Article

Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City

Related references

Note: Only part of the references are listed.
Article Ethics

Moving beyond mistrust: Centering institutional change by decentering the white analytical lens

Alyssa M. Newman

Summary: This article explores the discourse and debates surrounding medical mistrust, highlighting the limitations of focusing solely on historically exploited populations and overlooking the accountability of medical institutions. The shift towards examining institution trustworthiness is seen as narrowing the issue to specific communities, rather than addressing systemic issues within medical institutions and the healthcare system. The article suggests moving beyond the mistrust framework and white normativity to conduct a holistic analysis necessary for addressing racial health disparities.

BIOETHICS (2022)

Article Psychiatry

Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021

Lindsey Wang et al.

Summary: The study found that individuals with substance use disorders (SUDs) have a significantly higher risk of breakthrough COVID-19 infection after vaccination compared to those without SUDs, particularly for patients with cocaine and cannabis use disorders. When controlling for lifetime comorbidities and adverse socioeconomic determinants of health, the risk for breakthrough infection in SUD patients is no longer significantly different from non-SUD individuals, except for those with cannabis use disorder who remain at increased risk.

WORLD PSYCHIATRY (2022)

Article Psychology, Clinical

Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19

Robert Rosales et al.

Summary: The COVID-19 pandemic exacerbated health disparities experienced by individuals with opioid use disorder (OUD) from racial and ethnic minority groups, potentially due to disrupted access to harm reduction services. Research findings suggest that persons with OUD who self-identify as from racial/ethnic minority groups are more likely to experience disruptions in accessing harm reduction services, specifically in obtaining naloxone and sterile syringes, even after controlling for confounding variables. This highlights the need for targeted outreach strategies and policies to promote equitable access to essential harm reduction services.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Article Public, Environmental & Occupational Health

Neighborhood disparities in COVID-19 outcomes in New York city over the first two waves of the outbreak

Xiaobo Zhong et al.

Summary: This study aimed to assess the association between neighborhood demographic and socioeconomic characteristics and COVID-19 incidence and mortality in New York City (NYC) during the first two waves of the outbreak. The results showed that neighborhoods severely impacted in the first wave were also more affected in the second wave. Higher percentages of seniors, males, Black and Hispanic populations, and large-size households were associated with higher incidence rates of COVID-19 in the first wave but not in the second wave. Neighborhoods with higher percentages of Black and Hispanic populations and lower insurance coverage had higher death rates and case fatality ratios in the first wave, and neighborhoods with higher percentages of Black and Asian populations had an elevated case fatality ratio in the second wave. Median household income was negatively associated with incidence rate and death rate per capita but not associated with case fatality ratio in both waves. Neighborhoods with more seniors had higher death rates and case fatality ratios in both waves.

ANNALS OF EPIDEMIOLOGY (2022)

Article Substance Abuse

Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits - United States, April 2020-December 2020

Amy R. Board et al.

Summary: This study identified risk factors associated with COVID-19 among persons with substance use disorder. It found that age, sex, race/ethnicity, geographic region, insurance type, comorbidities, and type of substance use disorder (SUD) were associated with COVID-19 diagnosis among this population. The study also highlighted the importance of integrating COVID-related care, care for other comorbidities, and SUD treatment for persons with substance use disorder.

DRUG AND ALCOHOL DEPENDENCE (2022)

Article Substance Abuse

Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records

Deborah S. Hasin et al.

Summary: This study found that substance use disorders (SUD) are associated with COVID-19 hospitalization but not COVID-19 mortality. However, among COVID-19 positive patients, those who received SUD treatment had lower mortality rates.

DRUG AND ALCOHOL DEPENDENCE (2022)

Article Health Care Sciences & Services

Using a structural vulnerability framework to understand the impact of COVID-19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City

Jenny Zhen-Duan et al.

Summary: This study investigated the impact of the COVID-19 pandemic on low-income individuals with substance use disorder (SUD) in New York City. The findings suggest that COVID-19 exacerbated structural vulnerabilities among this population, but programmatic adaptations to SUD care during the pandemic helped mitigate past difficulties.

HEALTH SERVICES RESEARCH (2022)

Letter Medicine, General & Internal

Forecasted and Observed Drug Overdose Deaths in the US During the COVID-19 Pandemic in 2020

Abigail R. Cartus et al.

JAMA NETWORK OPEN (2022)

Article Medicine, General & Internal

Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration

Emily C. Williams et al.

Summary: This survey study suggests that existing diagnostic procedures and tools are insufficient to capture SUD prevalence rates, particularly among younger patients and Hispanic and Latinx patients. Clinics and health systems should implement standardized SUD assessments to ensure the provision of equitable care and the optimal identification of underlying conditions for performance monitoring.

JAMA NETWORK OPEN (2022)

Article Health Care Sciences & Services

Disease-Specific Factors Associated with Readmissions or Mortality After Hospital Discharge in COVID-19 Patients: a Retrospective Cohort Study

Cheng-Wei Huang et al.

Summary: In a retrospective cohort study of COVID-19 patients, factors such as age, Elixhauser index, treatment with remdesivir, and symptom duration at discharge were found to be associated with adverse events post-discharge. Treatment with remdesivir was inversely associated with adverse events, while symptom duration <= 10 days was positively associated. There was a significant interaction between remdesivir and symptom duration, indicating their combined impact on clinical decision making at discharge.

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Article Public, Environmental & Occupational Health

The Relationship Between Social Determinants of Health and Racial Disparities in COVID-19 Mortality

Ankur K. Dalsania et al.

Summary: The study shows a clear association between adverse social determinants of health and COVID-19 mortality rates, as well as racial disparities, at the county level. This highlights the need for public health policies addressing racial disparities in health outcomes.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2022)

Article Biochemistry & Molecular Biology

COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

Quan Qiu Wang et al.

Summary: This study identified individuals with SUD, especially those with OUD and African Americans, as having an increased risk for COVID-19 and worse outcomes. Screening and treating individuals with SUD is crucial in controlling the pandemic and ensuring healthcare support without disparities.

MOLECULAR PSYCHIATRY (2021)

Review Cardiac & Cardiovascular Systems

Missing Data in Clinical Research: A Tutorial on Multiple Imputation

Peter C. Austin et al.

Summary: Missing data is common in clinical research, with approaches like complete-case analysis, mean-value imputation, and multiple imputation used to address it. Multiple imputation is a popular method where multiple plausible values are imputed for each subject with missing data, resulting in multiple completed data sets for statistical analysis.

CANADIAN JOURNAL OF CARDIOLOGY (2021)

Article Health Care Sciences & Services

Derivation of a Clinical Risk Score to Predict 14-Day Occurrence of Hypoxia, ICU Admission, and Death Among Patients with Coronavirus Disease 2019

David M. Levine et al.

Summary: This study aimed to develop a risk score to predict suitability for discharge from a monitored setting among early COVID-19 patients. The risk score, based on age, oxygen saturation, and albumin level, showed a sensitivity of 83% and specificity of 82% at a cut point of 30. The score's c-statistic was 0.8939 for the derivation cohort and 0.8685 for the validation cohort, indicating its predictive performance.

JOURNAL OF GENERAL INTERNAL MEDICINE (2021)

Article Public, Environmental & Occupational Health

Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January-October 2020

Bennett Allen et al.

Summary: The study indicates that patients with histories of substance use disorder (SUD) and drug overdose may face elevated risk of adverse COVID-19 outcomes.

JOURNAL OF PUBLIC HEALTH (2021)

Article Medicine, General & Internal

Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021

Anna M. Acosta et al.

Summary: The study found that American Indian or Alaska Native, Latino, Black, and Asian or Pacific Islander individuals in the US were more likely than White individuals to experience COVID-19-associated hospitalization, ICU admission, or in-hospital death. Equitable access to COVID-19 preventive measures, including vaccination, is necessary to reduce racial and ethnic disparities in severe COVID-19.

JAMA NETWORK OPEN (2021)

Article Medicine, General & Internal

Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status A Systematic-Review and Meta-analysis

Shruti Magesh et al.

Summary: This study found that members of racial and ethnic minority groups had higher risks of COVID-19 positivity and disease severity. Furthermore, socioeconomic determinants were strongly associated with COVID-19 outcomes in racial and ethnic minority populations.

JAMA NETWORK OPEN (2021)

Article Medicine, General & Internal

Variation in COVID-19 Mortality in the US by Race and Ethnicity and Educational Attainment

Justin M. Feldman et al.

Summary: Racial and ethnic inequities in COVID-19 mortality exist in the US, with significant disparities based on race, ethnicity, and educational attainment. If all groups had experienced the same mortality rates as college-educated non-Hispanic White individuals, there would have been a 48% reduction in COVID-19 deaths among adults aged 25 years or older.

JAMA NETWORK OPEN (2021)

Editorial Material Medicine, General & Internal

Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals

Annette Flanagin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Psychiatry

Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis

Benedetta Vai et al.

Summary: This systematic review and meta-analysis found that pre-existing mental disorders, specifically psychotic and mood disorders, and exposure to antipsychotics and anxiolytics were associated with an increased risk of COVID-19 mortality. The study highlighted the need for targeted approaches to manage and prevent COVID-19 in at-risk patient groups identified in this study. Further research is needed to determine the underlying mechanisms of these associations.

LANCET PSYCHIATRY (2021)

Article Medicine, General & Internal

Race, ethnicity, community-level socioeconomic factors, and risk of COVID-19 in the United States and the United Kingdom

Chun-Han Lo et al.

Summary: This study found that compared with non-Hispanic White participants, the risk for a positive COVID-19 test was increased for non-Hispanic Black and Hispanic participants in the US, and for Black, South Asian, and Middle Eastern participants in the UK. This elevated risk was associated with living in more deprived communities according to the NDI/IMD indices.

ECLINICALMEDICINE (2021)

Article Psychology, Clinical

Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19

Max Jordan Nguemeni Tiako

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Letter Public, Environmental & Occupational Health

Disparities in the Population at Risk of Severe Illness From COVID-19 by Race/Ethnicity and Income

Matthew A. Raifman et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)

Letter Medicine, General & Internal

Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs

Rishi K. Wadhera et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Medicine, General & Internal

Racial Health Disparities and Covid-19-Caution and Context

Merlin Chowkwanyun et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Public, Environmental & Occupational Health

Health Disparities and the Heterogeneity of Blacks/African Americans in the United States: Why Should We Care?

Ann Oyare Amuta-Jimenez et al.

HEALTH PROMOTION PRACTICE (2020)

Editorial Material Medicine, General & Internal

Racial Differences in Opioid Overdose Deaths in New York City, 2017

Bennett Allen et al.

JAMA INTERNAL MEDICINE (2019)

Article Public, Environmental & Occupational Health

Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators

Priscila Corraini et al.

CLINICAL EPIDEMIOLOGY (2017)

Article Health Care Sciences & Services

Variation in Use of Buprenorphine and Methadone Treatment by Racial, Ethnic, and Income Characteristics of Residential Social Areas in New York City

Helena B. Hansen et al.

JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH (2013)

Article Medicine, General & Internal

Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis

Rolf H. H. Groenwold et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)

Review Substance Abuse

Effect of Methadone Maintenance Treatment on Heroin Craving, a Literature Review

Ayman Fareed et al.

JOURNAL OF ADDICTIVE DISEASES (2011)

Article Health Care Sciences & Services

Heterogeneity in Health Insurance Coverage Among US Latino Adults

Arturo Vargas Bustamante et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2009)

Article Health Care Sciences & Services

Adjusting for multiple testing - when and how?

R Bender et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)